Source: Virtual Congress 2021 – Environment and respiratory health



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gupta (Seattle, United States of America), C. Sack (Seattle, United States of America), L. Paulin (Lebanon, United States of America), A. Gassett (Seattle, United States of America), C. Sung (Seattle, United States of America), J. Hess (Seattle, United States of America), P. Woodruff (San Francisco, United States of America), M. Dransfield (Birmingham, United States of America), R. Paine (Salt Lake City, United States of America), I. Barjaktarevic (Los Angeles, United States of America), A. Comellas (Iowa City, United States of America), M. Karimi (Birmingham, United States of America), C. Pirozzi (Salt Lake City, United States of America), V. Ortega (Winston-Salem, United States of America), W. Labaki (Ann Arbor, United States of America), S. Bhatt (Birmingham, United States of America), N. Hansel (Baltimore, United States of America), J. Kaufman (Seattle, United States of America). Effects of ambient temperature on COPD symptoms and exacerbations in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort. 103

Member's Comments

No comment yet.

Related content which might interest you: Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Associations between comorbid load and baseline characteristics in COPD patients with comorbidities: Preliminary results Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Impact of airflow obstruction severity on the course of COPD during follow-up Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Risk factors for self-reported hospitalizations among stable outpatients with COPD Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 The Non-Invasive Ventilation Outcomes (NIVO) score in presumed COPD exacerbation without prior spirometry. Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores Year: 2020 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Effect of tiotropium on exhaled breath temperature in patients with COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Assessment of sleep disturbance during recovery from acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults Year: 2014 COPD exacerbation admissions: Analysis of demographics and mortality Source: Annual Congress 2013 –COPD treatment Year: 2013 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Value of adding treatment with lyophilized bacterial lysates in reducing COPD exacerbations in COPD patients risk group C and D Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine). Source: International Congress 2017 – COPD management Year: 2017 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 Physical status and dependence levels in patients with COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2014 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014